Understanding infliximab in Crohn's disease: The long-term outcomes

Dan Turner; Raffi Lev-Tzion

doi:10.1007/s10620-012-2504-x

Understanding infliximab in Crohn's disease: The long-term outcomes

Dan Turner^*
, Raffi Lev-Tzion

^*Corresponding author for this work

Institute for Medical Research Israel-Canada (IMRIC)

Research output: Contribution to journal › Review article › peer-review

7 Scopus citations

Original language	English
Pages (from-to)	604-607
Number of pages	4
Journal	Digestive Diseases and Sciences
Volume	58
Issue number	3
DOIs	https://doi.org/10.1007/s10620-012-2504-x
State	Published - Mar 2013

Access to Document

10.1007/s10620-012-2504-x

Cite this

@article{dd53cfa20b7a4c86b92f2cd97c94f5d4,

title = "Understanding infliximab in Crohn's disease: The long-term outcomes",

author = "Dan Turner and Raffi Lev-Tzion",

year = "2013",

month = mar,

doi = "10.1007/s10620-012-2504-x",

language = "אנגלית",

volume = "58",

pages = "604--607",

journal = "Digestive Diseases and Sciences",

issn = "0163-2116",

publisher = "Springer",

number = "3",

}

TY - JOUR

T1 - Understanding infliximab in Crohn's disease

T2 - The long-term outcomes

AU - Turner, Dan

AU - Lev-Tzion, Raffi

PY - 2013/3

Y1 - 2013/3

UR - https://www.scopus.com/pages/publications/84876675211

U2 - 10.1007/s10620-012-2504-x

DO - 10.1007/s10620-012-2504-x

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.systematicreview???

C2 - 23263930

AN - SCOPUS:84876675211

SN - 0163-2116

VL - 58

SP - 604

EP - 607

JO - Digestive Diseases and Sciences

JF - Digestive Diseases and Sciences

IS - 3

ER -

Understanding infliximab in Crohn's disease: The long-term outcomes

Access to Document

Other files and links

Cite this